Inventor · disambiguated record
Claude Leclerc
Also filed as: LECLERC CLAUDE
26 granted patents·17 pending applications·542 citations·filing 1993–2017
96Inventor score
Files withPASTEUR INSTITUT19LECLERC CLAUDE7DADAGLIO GILLES4BAY SYLVIE2PREVILLE XAVIER-EDMOND-EDOUARD2
Top patents by PatentIndex Score
43 records- 0193US5871747AAntigen-carrying microparticles and their use in the indication of humoral or cellular responsesPASTEUR INSTITUT·Filed 1993·Granted Feb 16, 1999·243 cites·27 claims
- 0285US6004763AAntigen-carrying microparticles and their use in the induction of humoral or cellular responsesPASTEUR INSTITUT·Filed 1998·Granted Dec 21, 1999·99 cites·23 claims
- 0385US5503829ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1994·Granted Apr 2, 1996·58 cites·9 claims
- 0483US9095537B2Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune responseLECLERC CLAUDE·Filed 2007·Granted Aug 4, 2015·5 cites·32 claims
- 0583US8628779B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2006·Granted Jan 14, 2014·8 cites·43 claims
- 0681US8017132B2Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cellPASTEUR INSTITUT·Filed 2009·Granted Sep 13, 2011·8 cites·19 claims
- 0781US7906123B1Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereofPASTEUR INSTITUT·Filed 2007·Granted Mar 15, 2011·8 cites·17 claims
- 0879US8637039B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2010·Granted Jan 28, 2014·5 cites·45 claims
- 0975US8747866B2Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microtiCOLE STEWART·Filed 2010·Granted Jun 10, 2014·5 cites·48 claims
- 1075US5679784ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1995·Granted Oct 21, 1997·23 cites·10 claims
- 1174US9957301B2Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune responsePASTEUR INSTITUT·Filed 2015·Granted May 1, 2018·2 cites·6 claims
- 1272US5935580ARecombinant mutants for inducing specific immune responsesPASTEUR INSTITUT·Filed 1995·Granted Aug 10, 1999·33 cites·15 claims
- 1371US9410139B2Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2008·Granted Aug 9, 2016·3 cites·5 claims
- 1471US6676946B2Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereofPASTEUR INSTITUT·Filed 1999·Granted Jan 13, 2004·24 cites·3 claims
- 1569US9370564B2Vectors for molecule delivery to CD11b expressing cellsLECLERC CLAUDE·Filed 2011·Granted Jun 21, 2016·2 cites·22 claims
- 1668US8398991B2Modified ESAT-6 molecules and improved vaccine strains of Mycobacterium bovis BCGBROSCH ROLAND·Filed 2006·Granted Mar 19, 2013·2 cites·10 claims
- 1765US7883712B2Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microtiPASTEUR INSTITUT·Filed 2003·Granted Feb 8, 2011·1 cites·18 claims
- 1859US9387243B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPASTEUR INSTITUT·Filed 2013·Granted Jul 12, 2016·0 cites·33 claims
- 1955US10899799B2Method for preparing multiple antigen glycopeptide carbohydrate conjugatesPASTEUR INSTITUT·Filed 2017·Granted Jan 26, 2021·0 cites·13 claims
- 2054US10004794B2Vectors for molecule delivery to CD11b expressing cellsPASTEUR INSTITUT·Filed 2016·Granted Jun 26, 2018·0 cites·16 claims
- 2154US7696326B2Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereofPASTEUR INSTITUT·Filed 2007·Granted Apr 13, 2010·0 cites·1 claims
- 2254US2004058859A1Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereofPASTEUR INSTITUT·Filed 2003·Application pending·0 cites
- 2351US2005238637A1Vectors for molecule delivery to CD11b expressing cellsCENTRE NAT RECH SCIENT·Filed 2005·Application pending·0 cites
- 2450US2005271679A1Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2004·Application pending·0 cites
- 2550US2014227323A1Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigensDADAGLIO GILLES·Filed 2013·Application pending·0 cites
- 2649US9155783B2Agents and methods based on the use of the EDA domain of fibronectinLECLERC CLAUDE·Filed 2006·Granted Oct 13, 2015·0 cites·25 claims
- 2749US2011268757A1Use of phenol-soluble modulins for vaccine developmentPASTEUR INSTITUT·Filed 2009·Application pending·0 cites
- 2846US6458362B1Recombinant VP2 parvoviral pseudo-particles encoding CTL or T-helper cell epitopesPASTEUR INSTITUT·Filed 1996·Granted Oct 1, 2002·13 cites·14 claims
- 2946US2014378652A9Method for preparing multiple antigen glycopeptide carbohydrate conjugatesBAY SYLVIE·Filed 2012·Application pending·0 cites
- 3046US2010310594A1Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigensINST PASTEUR A CORP OF FRANCE·Filed 2010·Application pending·0 cites
- 3146US2004001867A1Vectors for molecule delivery to CD11b expressing cellsFiled 2003·Application pending·0 cites
- 3246US2009317854A1Recombinant adenylate cyclase of BORDETELLA SP. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseINST PASTEUR INSERM I NAT DE L·Filed 2008·Application pending·0 cites
- 3344US9708596B2Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cellPASTEUR INSTITUT·Filed 2015·Granted Jul 18, 2017·0 cites·9 claims
- 3444US2007026022A1Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigensDADAGLIO GILLES·Filed 2006·Application pending·0 cites
- 3544US2006159697A1Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereofLECLERC CLAUDE·Filed 2005·Application pending·0 cites
- 3643US9657074B2Enzymatic large-scale synthesis of mucin glyconjugates, and immunogenic applications thereofBAY SYLVIE·Filed 2006·Granted May 23, 2017·0 cites·12 claims
- 3743US2007237785A1Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereofPASTEUR INSTITUT·Filed 2006·Application pending·0 cites
- 3842US2006286613A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2006·Application pending·0 cites
- 3940US2013121958A1Streptavidin and biotin-based antigen delivery systemLECLERC CLAUDE·Filed 2010·Application pending·0 cites
- 4038US2006019323A1Recombinant adenylate cyclase of Bordetella sp. for diagnostic and immunomonitoring uses, method of diagnosing or immunomonitoring using said recombinant adenylate cyclase, and kit for diagnosing or immunomonitoring comprising said recombinant adenylate cyclaseLECLERC CLAUDE·Filed 2004·Application pending·0 cites
- 4136US9222143B2Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cellSEBO PETER·Filed 2010·Granted Dec 29, 2015·0 cites·11 claims
- 4234US2012052083A1MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELLSEBO PETER·Filed 2011·Application pending·0 cites
- 4331US2016215039A1Agents and methods based on the use of the eda domain of fibronectinPROYECTO DE BIOMEDICINA CIMA S L·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →